MPS Loria Financial Planners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

MPS Loria Financial Planners’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$3K	–	621
2021 Q1	$3K	Hold	100	–	–	﹤0.01%	416
2020 Q4	$2K	Hold	100	–	–	﹤0.01%	504
2020 Q3	$0	Buy	+100	New	+$508	﹤0.01%	352

MPS Loria Financial Planners's FPRX Position: Q2 2021 in Review

MPS Loria Financial Planners sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 100 shares — an estimated $3K sold.

MPS Loria Financial Planners first reported a position in FPRX in Q3 2020 and held it in 3 quarters. The position peaked at $3K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

MPS Loria Financial Planners reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
MPS Loria Financial Planners sold 100 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $3K.
MPS Loria Financial Planners first reported a position in Five Prime Therapeutics, Inc. in Q3 2020 and held it in 3 quarters.
MPS Loria Financial Planners's Five Prime Therapeutics, Inc. position peaked at $3K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on MPS Loria Financial Planners's 13F filing for Q2 2021, filed 20 Jul 2021.